Related Experiment Video

Updated: Oct 11, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.9K

Aerosolized drug delivery in awake and anesthetized children to treat bronchospasm

Natalie Anderson1,2, Sarah Clarke3, Britta S von Ungern-Sternberg1,4,5

  • 1Perioperative Medicine, Telethon Kids Institute, Nedlands, WA, Australia.

Paediatric Anaesthesia
|December 4, 2021
PubMed

Insights

This review covers best practices for delivering inhaled medications like salbutamol to pediatric patients during anesthesia and emergencies. It highlights the need for better inhaled drug delivery innovations for critical respiratory events.

Area of Science:

  • Pediatric Anesthesiology
  • Respiratory Medicine
  • Pharmacology

Background:

  • Bronchospasm is a frequent respiratory complication in pediatric anesthesia.
  • Inhaled salbutamol is the primary treatment for pediatric bronchospasm.
  • Effective aerosolized medication delivery is crucial for managing respiratory distress in children.

Purpose of the Study:

  • To review current best practices for aerosolized medication delivery in pediatric patients, both awake and anesthetized.
  • To compare various airway devices and administration techniques for aerosol delivery.
  • To identify the need for innovative orally inhaled drug products for pediatric respiratory emergencies.

Main Methods:

  • Literature review of current best practices in aerosolized drug delivery for pediatric patients.
  • Analysis of different airway devices and their impact on medication administration.
  • Discussion of advantages and disadvantages of various aerosol delivery techniques.

Main Results:

  • Current methods for aerosolized medication delivery in pediatric patients have limitations.
  • There is a significant need for improved and innovative orally inhaled drug products.
  • Understanding airway device differences is key to optimizing drug delivery.

Conclusions:

  • Optimizing aerosolized drug delivery is essential for preventing and treating pediatric bronchospasm.
  • Innovation in orally inhaled products is required to address unmet needs in pediatric respiratory care.
  • Clinicians must stay updated on best practices for managing pediatric respiratory emergencies.

Keywords:
aerosolanesthesianebulizerpediatricperioperative adverse eventssalbutamol

More Related Videos

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

6.3K
Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals04:22

Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

Published on: March 30, 2017

7.8K

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
469
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
620
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
707
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
523
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
670